肝胰岛素抵抗的新指标
摘要
流行病学和遗传学研究需要新指标来考察对胰岛素敏感的不同组织中的胰岛素抵抗（IR）情况。
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2011年第5期395-395,共1页
Chinese Journal of Diabetes
参考文献10
-
1Maria CR,Antonio N.Liraglutide in type 2 diabetes: from pharmacological development to clinical practice[].ACTA BIOMED.2009
-
2Zinman B,Gerich J,Buse JB, et al.Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD)[].Diabetes Care.2009
-
3Zinman B,Buse J,Falahati A. et al.Attaining a clinically relevant endpoint of HbAi c<7. 0%, no weight gain and no hypogly-caemia with liraglutide as compared to other therapies in type 2 diabetes mellitus (T2DM): meta-analysis of the LEAD studies[].Diabetologia.2009
-
4Zinman B.Liraglutide more effectively achieves a composite end-point for A1C, SBP and weight change than other diabetes therapies[].Diabetes.2009
-
5Russel-Jones D,Vaag A,Schmitz O et al.Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met +SU): a randomised controlled trial[].Diabetologia.2009
-
6Garber AJ,Henry R,Ratner R, et al.Monotherapy with liraglutide, a once-daily human GLP-1 analog, provides sustained reductions in Ale, FPG and weight compared with glimepiride in type 2 diabetes: LEAJD-3 mono 2-year results[].Diabetes.2009
-
7Sean D Sullivan.Improvement in cardiovascular risk factors and long-term outcomes in people with T2D treated with liraglutide or glimepiride monotherapy[].Diabetes.2009
-
8Buse J,Sesti G,Schmidt WE, et al.Switching from twice-daily exenatide to once-daily liraglutide improves glycemic con-trol in T2D on oral agents[].Diabetes.2009
-
9.
-
10Schmidt WE.Liraglutide, a human GLP-1 analogue, lowers HbAi c independent of weight loss[].Diabetologia.2009
-
1秦鸿,张庆.联合抗生素治疗医院获得性肺炎的可行性及安全性研究[J].现代诊断与治疗,2016,27(18):3403-3404. 被引量：1
-
2王强.静脉溶栓治疗急性心肌梗死的疗效及预后评估[J].中西医结合心血管病电子杂志,2015,3(21):50-50. 被引量：2
-
3董光龙,徐晓.胃转流术治疗2型糖尿病的机制[J].中华胃肠外科杂志,2014,17(7):737-740. 被引量：10
-
4柴铁玲.类风湿性关节炎动物模型在中医药研究中的进展及思考[J].环球中医药,2011,4(3):215-217. 被引量：12
-
5聂岭,李庆国,范阜东,王东进.小鼠心肌补片模型的建立[J].中华实验外科杂志,2010,27(11):1703-1703. 被引量：1
-
6彭代平,万春平,颜永明,汤小虎.类风湿关节炎动物模型在中医药研究中的概述[J].辽宁中医杂志,2014,41(8):1768-1770. 被引量：5
-
7曹金光,罗建平.乌司他丁联合奥曲肽对急性胰腺炎的临床疗效及对IL-1、IL-6、IL-10、IL-12水平的影响[J].中国实用医药,2014,9(21):183-184. 被引量：4
-
8杜兆江,李鹏,惠延年,王百忍,段小莉,张瑞.Ets-1在链脲左菌素诱导的糖尿病大鼠模型视网膜内表达增强(英文)[J].国际眼科杂志,2007,7(1):19-22.
-
9唐海波.静脉血栓栓塞症的防治[J].中国医药指南,2011,9(6):48-49. 被引量：2
-
10张一颖,张丽丽,申鹏飞,杜宇征,王舒.血管内皮及其分泌因子在血压调节中作用机制[J].辽宁中医药大学学报,2015,17(3):60-64. 被引量：15
